Fetal Echocardiography Clinical Trial
Official title:
Sief_Twist Sign a Novel View in Fetal Echocardiography
NCT number | NCT04596423 |
Other study ID # | AUE202010 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2020 |
Est. completion date | February 4, 2024 |
Verified date | February 2024 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To describe Sief_twist sign as a novel sign in fetal echocardiography as a new ,easy , time effective view in fetal heart examination .
Status | Completed |
Enrollment | 600 |
Est. completion date | February 4, 2024 |
Est. primary completion date | October 1, 2023 |
Accepts healthy volunteers | |
Gender | Female |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: 1. Singleton fetus . 2. gestational age 14-37 weeks. 3. no maternal medical disorder . 4. no morbed obisity. Exclusion Criteria: 1. evidence of fetal infection. 2. chorioamnionitis. 3. fetal anomalies. 4. abnormal fetal karyotype 5. patient withdrawal from the study and/or unavailability for follow-up. |
Country | Name | City | State |
---|---|---|---|
Egypt | Assiut university | Assuit |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | obtaining clear images for fetal cardiac structures via standard views which is 4 chamber view[4CH.], left outflow tract view[LVOT.] , right outflow tract view [RVOT.], three vesseles trachea view [3VTV.] | 4 chamber view that describe 4 heart chambers which are 2 atria , 2 ventricles - LVOT. view describes outflow of aorta from left ventricle in normal heart - RVOT describe outflow of pulmonary from rt. ventricle in normal heart - 3VTV describes view of aorta, pulonary and superior viena cava at upper chest | 15 miutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05940363 -
The National Program for the Improvement of Management of Fetal Congenital Heart Disease in China
|